Riskpilot← Back to searchSign inGet full accessKviberg Method AB
ABActiveOrg 5594217696Economic activity was not specified by tax authority · NACE 0000Est. 20230 employees
Revenue 2025
SEK 0
EBITDA margin
—
+17% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -2K
+17% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +17% |
| Net profit | SEK -2K | +17% |
| Total assets | SEK 46K | -4% |
| Equity | SEK 46K | -4% |
| Employees | 0 | — |
Legal name
Kviberg Method AB
Org number
5594217696
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
13 februari 2023
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Kviberg Method kommer att bedriva verksamhet inom programvara för utbildning och diagnostisering, certifieringstjänster och vetenskaplig forskning kring bäckendysfunktion, torticollis samt NPF. Hälsovård avseende fysioterapi, behandlingstjänster, diagnostisering, rehabilitering och medicinska kliniker. Utbildningsmaterial och litteratur, examinationstjänster och medicinsk utbildning.
Address
Email
anna.orbe@indea.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −2 | −2 |
| Depreciation & amort. | — | — |
| EBIT | −2 | −2 |
| Net financials | — | — |
| Profit before tax | −2 | −2 |
| Tax | — | — |
| Net profit | −2 | −2 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 48 | 46 |
| Equity | 48 | 46 |
| Long-term debt | — | — |
| Short-term debt | — | — |
| Total debt | — | — |
EBITDA margin
-190000.0%
This company
15.8%
Market median
-1202632% vs market
20242025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20242025
Return on equity
-4.1%
This company
18.4%
Market median
-122% vs market
20242025
Net profit margin
-190000.0%
This company
8.1%
Market median
-2345779% vs market
20242025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20242025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-13 – 2024-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EK | Audit | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kviberg Method AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Kristina Sofia Witt | Audit | 0 companies |
| Michael Carl Philip Orbe Dahl | Deputy Board Member | 0 companies |
| Maria Helen Orbe Dahl | Board of Directors | 0 companies |
| Anna Maria Orbe | Chairman | 0 companies |